Status:
COMPLETED
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
Lead Sponsor:
St. Luke's Medical Center, Philippines
Conditions:
Prostate Cancer
Prostatitis
Eligibility:
MALE
18+ years
Brief Summary
This study will identify significant clinical parameters and individual risk factors related to certain prostate disease (BPH, prostatitis and prostate cancer). With the identified important correlati...
Detailed Description
This is a cross-sectional study prospectively collecting data from all patients who had their first Transrectal ultrasound (TRUS) prostate biopsy at the Stone and Prostate Treatment Center of St. Luke...
Eligibility Criteria
Inclusion
- All patients who had their first Transrectal ultrasound (TRUS) prostate biopsy at the Stone and Prostate Treatment Center of St. Luke's Medical Center-Quezon City . The indication for prostate biopsy is either a suspicious DRE findings or elevated PSA level (\>4.0ng/ml) or both.
Exclusion
- non-Asian patient
- incomplete data provided and patients refused to provide required data
- Prostate specific antigen done other than St. Luke's Medical Center
- did not consent for biopsy procedure
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01826617
Start Date
December 1 2010
End Date
December 1 2014
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stone and Prostate Treatment Center- St. Luke's Medical Center, Philippines
Quezon City, National Capital Region, Philippines, 1102